Crystal structure of a soluble cleaved HIV-1 envelope trimer

Science

Volumn 342, Issue 6165, 2013, Pages 1477-1483

  Julien, Jean Philippe ^a   Cupo, Albert ^b   Sok, Devin ^a   Stanfield, Robyn L ^a   Lyumkis, Dmitry ^a   Deller, Marc C ^a   Klasse, Per Johan ^b   Burton, Dennis R ^a,c   Sanders, Rogier W ^b,d   Moore, John P ^b   Ward, Andrew B ^a   Wilson, Ian A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HARVARD UNIVERSITY   (United States)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; EPITOPE; GLYCAN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN;

ANTIBODY; CRYSTAL STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE SYSTEM; PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4+ T LYMPHOCYTE; CELL STRAIN HEK293; CRYOELECTRON MICROSCOPY; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ANALYSIS; TARGET CELL; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84890858459     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1245625     Document Type: Article

References (63)

1. L. Kong et al., Nat. Struct. Mol. Biol. 20, 796-803 (2013).
2. Y. D. Kwon et al., Proc. Natl. Acad. Sci. U.S.A. 109, 5663-5668 (2012).
3. P. D. Kwong et al., Nature 393, 648-659 (1998).
4. J. S. McLellan et al., Nature 480, 336 -343 (2011).
5. M. Pancera et al., Proc. Natl. Acad. Sci. U.S.A. 107, 1166-1171 (2010).
6. M. Pancera et al., Nat. Struct. Mol. Biol. 20, 804-813 (2013).
7. R. Pejchal et al., Science 334, 1097-1103 (2011).
8. T. Zhou et al., Science 329, 811-817 (2010).
9. T. Zhou et al., Nature 445, 732-737 (2007).
10. R. Diskin et al., Science 334, 1289-1293 (2011).
11. J. Liu, A. Bartesaghi, M. J. Borgnia, G. Sapiro, S. Subramaniam, Nature 455, 109-113 (2008).
12. E. E. Tran et al., PLOS Pathog. 8, e1002797 (2012).
13. M. A. Checkley, B. G. Luttge, E. O. Freed, J. Mol. Biol. 410, 582-608 (2011).
14. J. M. McCune et al., Cell 53, 55-67 (1988).
15. S. A. Gallo et al., Biochim. Biophys. Acta 1614, 36-50 (2003).
16. R. W. Sanders et al., J. Virol. 76, 8875-8889 (2002).
17. R. W. Sanders et al., PLOS Pathog. 9, e1003618 (2013).
18. J. P. Julien et al., Proc. Natl. Acad. Sci. U.S.A. 110, 4351-4356 (2013).
19. R. Khayat et al., J. Virol. 87, 9865-9872 (2013).
20. P. J. Klasse et al ., J. Virol. 87, 9873-9885 (2013).
21. L. M. Walker et al., Nature 477, 466-470 (2011).
22. Materials and methods are available as supplementary materials on Science Online.
23. J. P. Julien et al., PLOS Pathog. 9, e1003342 (2013).
24. O. Rosen, M. Sharon, S. R. Quadt-Akabayov, J. Anglister, Proc. Natl. Acad. Sci. U.S.A. 103, 13950-13955 (2006).
25. D. Lyumkis et al., Science 342, 1484-1490 (2013).
26. The BG505 SOSIP.664 trimer possesses most, if not all, of the characteristics associated with the prefusion closed Env trimer conformation: the presence of a V1V2/V3 cap assembled at the membrane-distal apex; antigenic reactivity with antibodies to quaternary epitopes; the likely inability of gp41 to bind to free HR2 peptides; a coherent binding site for residues associated with binding of the small-molecule inhibitor of HIV-1 entry, BMS806; and many residues of the inner domain previously analyzed by mutational substitution for which we can now explain their mutational phenotypes.
27. Y. Mao et al., Proc. Natl. Acad. Sci. U.S.A. 110, 12438-12443 (2013).
28. Y. Mao et al., Nat. Struct. Mol. Biol. 19, 893-899 (2012).
29. A hole was also reported in cleaved trimer structures determined by EM (11) but seems to result from the low resolution of the reconstructions [see discussion in (25)].
30. J. Cohen, Science 341, 443-444 (2013).
31. R. Henderson, Proc. Natl. Acad. Sci. U.S.A. 110, 18037-18041 (2013).
32. S. Subramaniam, Proc. Natl. Acad. Sci. U.S.A. 110, E4172-E4174 (2013).
33. M. van Heel, Proc. Natl. Acad. Sci. U.S.A. 110, E4175-E4177 (2013).
34. Y. Mao, L. R. Castillo-Menendez, J. G. Sodroski, Proc. Natl. Acad. Sci. U.S.A. 110, E4178-E4182 (2013).
35. L. Chen et al ., Science 326, 1123-1127 (2009).
36. R. Stanfield et al., Structure 7, 131-142 (1999).
37. X. Jiang et al., Nat. Struct. Mol. Biol. 17, 955-961 (2010).
38. C. C. Huang et al., Science 310, 1025-1028 (2005).
39. P. Kolchinsky, E. Kiprilov, J. Sodroski, J. Virol. 75, 2041-2050 (2001).
40. P. Kolchinsky, E. Kiprilov, P. Bartley, R. Rubinstein, J. Sodroski, J. Virol. 75, 3435-3443 (2001).
41. P. Rusert et al., J. Exp. Med. 208, 1419-1433 (2011).
42. L. Liu, R. Cimbro, P. Lusso, E. A. Berger, Proc. Natl. Acad. Sci. U.S.A. 108, 20148-20153 (2011).
43. A. Finzi et al., Mol. Cell 37, 656- 667 (2010).
44. Stronger electron density reappears for a loop before the N terminus of the gp41 HR1 central helix, near the gp120/gp41 interface. We assign this electron density to the gp41 FP proximal region elements. gp41 and gp120 elements in this region (gp120 residues 73 to 84, glycans at gp120 N88 and gp41 N625, and the C-terminal HR2 helix from an adjacent protomer) are particularly hydrophobic and could easily interact with and occlude the hydrophobic gp41 FP. In addition, this ascribed FP region is in close relative proximity to the C terminus of gp120 C5, to which it was connected in the uncleaved gp160 precursor before furin cleavage.
45. I. A. Wilson, J. J. Skehel, D. C. Wiley, Nature 289, 366-373 (1981).
46. P. A. Bullough, F. M. Hughson, J. J. Skehel, D. C. Wiley, Nature 371, 37-43 (1994).
47. M. Kielian, F. A. Rey, Nat. Rev. Microbiol. 4, 67-76 (2006).
48. J. S. McLellan et al., Science 340, 1113-1117 (2013).
49. J. E. Lee et al., Nature 454, 177-182 (2008).
50. V. Buzon et al., PLOS Pathog. 6, e1000880 (2010).
51. A slight difference in HR2 helix orientation is observed between the trimer crystal structure and the cryo-EM structure reported in the accompanying manuscript (25). Crystal packing interactions at the gp41 C terminus probably account for this small shift (fig. S2).
52. J. M. Binley et al., J. Virol. 74, 627-643 (2000).
53. J. Huang et al., Nature 491, 406-412 (2012).
54. J. P. Julien, S. Bryson, J. L. Nieva, E. F. Pai, J. Mol. Biol. 384, 377-392 (2008).
55. H. Mouquet et al., Proc. Natl. Acad. Sci. U.S.A. 109, E3268-E3277 (2012).
56. B. Moldt et al., Proc. Natl. Acad. Sci. U.S.A. 109, 18921-18925 (2012).
57. R. Sadjadpour et al., J. Virol. 87, 8798-8804 (2013).
58. The complex biantennary glycan observed in the PGT121 paratope in crystal structures (23, 55) is fortuitous, as the glycan comes from a symmetry-related PGT121 Fab molecule in the crystal. Fab PGT121 is glycosylated and was expressed in mammalian cells. PGT121 also reacts on the glycan array with complex biantennary glycans possessing α1-6 sialylated ends (23), which make substantial contacts with the paratope in the crystal structures. Although the N137 glycoform remains uncharacterized on virus-derived HIV-1 Env, PGT121 reactivity with the glycan array, and the liganded crystal structures, suggest that N137 is probably a biantennary complex glycan. The relatively weaker electron density for the oligomannose N137 glycan in the trimer structure also suggests that, when it is not an α1-6 sialylated complex carbohydrate, the N137 glycan lacks major putative sites of interaction with PGT122. Hence, it might not be fully protected from glycosidase treatment, or it may be slightly disordered.
59. L. M. Walker et al., Science 326, 285-289 (2009).
60. The PGT122 and PGT128 bnAbs appear to recognize a closely related N332-dependent epitope, but they approach gp120 with an inverted disposition of their light and heavy chains. Whereas the PGT128 heavy chain predominantly interacts with the gp120 V3 base, PGT122 recognizes this region mainly through its light chain. Conversely, N137 is recognized by the PGT122 heavy chain but is putatively contacted by the PGT128 light chain.
61. N. Sullivan, M. Thali, C. Furman, D. D. Ho, J. Sodroski, J. Virol. 67, 3674-3679 (1993).
62. S. H. Xiang et al., J. Virol. 84, 3147-3161 (2010).
63. The PyMOL Molecular Graphics System, version 1.6.0.0, Schrödinger, LLC.